3653 results for «439»
3653 results
Drug-coated balloons: a PREVAIL-ing gamechanger in complex PCI
11 Oct 2025 – From AICT-AsiaPCR 2025
Focus on the evolving role of drug-coated balloons (DCB) in complex PCI, extending their use beyond traditional indications to challenging coronary lesions and high-risk patient populations. This session reviews clinical data from the SCAAR Prevail registry and discusses the evidence journey supporting broader advocacy for DCB...
AICT-AsiaPCR 2025 Awards ceremony
11 Oct 2025 – From AICT-AsiaPCR 2025
The AICT-AsiaPCR 2025 Awards ceremony celebrates outstanding achievements and innovations in the field of interventional cardiology. This event recognizes the contributions of clinicians and researchers who have advanced cardiovascular care and highlights excellence across various domains within the specialty.
AICT-AsiaPCR 2025 Closing ceremony
11 Oct 2025 – From AICT-AsiaPCR 2025
The AICT-AsiaPCR 2025 Closing ceremony marks the culmination of a comprehensive Course, reflecting on key scientific advancements, collaborative achievements, and the shared commitment to advancing cardiovascular medicine and patient care.
AICT-AsiaPCR 2025 Opening ceremony
10 Oct 2025 – From AICT-AsiaPCR 2025
The AICT-AsiaPCR 2025 Opening Ceremony marked the commencement of the conference's comprehensive program, setting the stage for cutting-edge discussions and advancements in interventional cardiology across the Asia-Pacific region.
CTO techniques and strategies
11 Oct 2025 – From AICT-AsiaPCR 2025
Explore advanced techniques and strategic approaches in chronic total occlusion (CTO) interventions, including novel methods for severely calcified lesions, bifurcation management, and complex anatomies such as right main CTOs. The session highlights epicardial collateral navigation, device synergy for calcified coronary disease, indigenous perforation techniques, and ultra-low...
Retrievals, foreign bodies and entrapments
11 Oct 2025 – From AICT-AsiaPCR 2025
This session addresses the complexities of retrievals, foreign bodies, and entrapments in interventional cardiology. It presents clinical cases illustrating percutaneous retrieval techniques, management of catheter fractures, iatrogenic dissections, and innovative solutions for challenging scenarios. Emphasis is placed on precision, prevention strategies, and effective problem-solving to mitigate...
Coronary complications and rescue cases
11 Oct 2025 – From AICT-AsiaPCR 2025
This compelling session addresses complex coronary complications and rescue cases encountered in the cath lab. Through a series of challenging case studies, it highlights critical scenarios such as silent coronary artery threats, procedural nightmares, coronary perforations, and innovative rescue strategies that transform high-risk situations into successful...
TAVI and aortic valve procedures
11 Oct 2025 – From AICT-AsiaPCR 2025
Focusing on transcatheter aortic valve interventions, this session covers a broad spectrum of complex cases including emergent TAV-in-SAV procedures, management of severely calcified bicuspid valves, zero-contrast TAVI techniques, and strategies for hostile anatomies. It provides valuable insights into procedural planning and follow-up to optimize patient care...
EuroPCR 2026 – Coronary revascularisation in patients undergoing TAVI
20 May 2026
Paris, France, 19−22 May 2026. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during EuroPCR 2026 and are set to impact practice worldwide. Among them is an individual participant data meta-analysis of 4 randomised controlled trials...
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
07 Nov 2022
Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.
This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...
Author
Three-year results of HOST-POLYTECH-ACS RCT comparing durable- vs. degradable-polymer DES
30 Aug 2023
Alex Sticchi provides his take on the 3-year results of HOST-POLYTECH-ACS RCT which were presented by Hyo-Soo Kim during the ESC 2023 congress in Amsterdam.
Author
Evidence base: A description of the key, so far published, studies in the space of drug coated balloons
23 Jan 2025
Authored by Hector Garcia-Garcia and Jorge Sanz-Sanchez, this article examines pivotal randomized clinical trials on drug-coated balloons in coronary artery disease. It highlights their role in managing in-stent restenosis, de novo small vessel lesions, and large vessel lesions while exploring future directions through ongoing trials.
Author
Author
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome
02 Sep 2025
Daniele Giacoppo reports and provides his perspective on the main results of the ambitious NEOMINDSET trial, presented by Pedro Lemos from the Hospital Israelita Albert Einstein, São Paulo, Brazil, during a Late Breaking Trials session at the ESC Congress 2025 in Madrid, and simultaneously published in the New...
Author
